Category: Company news

Probe assists with antibiotic study

Probe is pleased to announce that it has supplied MicroEye to Department of Clinical Pharmacy, Isala in Zwolle, Netherlands as part of a study to monitor blood and tissue levels of flucloxacillin in patients with a staphylococcus aureus bacteremia.

Good early results from drug monitoring project

Exciting news from Probe’s NanoDem project to develop a novel therapeutic drug monitoring point-of-care-testing device for the measurement of immunosuppressants in transplanted patients, based on the MicroEye®.